Angiotensin II Reduces Cardiac AdipoR1 Expression through AT1 Receptor/ROS/ERK1/2/c-Myc Pathway

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Li, Li ^a   Zhang, Zhi Guo ^a   Lei, Hong ^a   Wang, Cheng ^a   Wu, Li Peng ^a   Wang, Jin Yu ^a   Fu, Feng Ying ^b   Zhu, Wei Guo ^a   Wu, Li Ling ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYL COENZYME A CARBOXYLASE; ACETYLCYSTEINE; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; APOCYNIN; DNA; GLYCOPROTEIN GP 91; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYC PROTEIN; REACTIVE OXYGEN METABOLITE; ROTENONE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME PHOSPHORYLATION; HEART CELL CULTURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION;

ACETYL-COA CARBOXYLASE; ADENYLATE KINASE; ADIPONECTIN; ADIPOSE TISSUE; ANGIOTENSIN II; ANIMALS; ANIMALS, NEWBORN; BLOOD VESSELS; CARDIOMEGALY; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MALE; MAP KINASE SIGNALING SYSTEM; MEMBRANE GLYCOPROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SKELETAL; MYOCYTES, CARDIAC; NADPH OXIDASE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ADIPONECTIN;

RATTUS;

EID: 84872785908     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049915     Document Type: Article

References (52)

1. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I, (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24: 29-33.
2. Hopkins TA, Ouchi N, Shibata R, Walsh K, (2007) Adiponectin actions in the cardiovascular system. Cardiovasc Res 74: 11-18.
3. Tobias P, Cynthia JG, Gokhan SH, Nader R, Frank BH, et al. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291: 1730-1737.
4. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, et al. (2004) Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43: 1318-1323.
5. Kozakova M, Muscelli E, Flyvbjerg A, Frystyk J, Morizzo C, et al. (2008) Adiponectin and left ventricular structure and function in healthy adults. J Clin Endocrinol Metab 93: 2811-2818.
6. Mitsuhashi H, Yatsuya H, Tamakoshi K, Matsushita K, Otsuka R, et al. (2007) Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension 49: 1448-1454.
7. Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, et al. (2004) Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10: 1384-1389.
8. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nat Med 423: 762-769.
9. Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, et al. (2004) Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279: 30817-30822.
10. Li R, Xu M, Wang X, Wang Y, Lau WB, et al. (2010) Reduced vascular responsiveness to adiponectin in hyperlipidemic rats-mechanisms and significance. J Mol Cell Cardiol 49: 508-515.
11. Saito Y, Fujioka D, Kawabata K, Kobayashi T, Yano T, et al. (2007) Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-α-treated cardiomyocytes in association with improved glucose uptake. Am J Physiol Heart Circ Physiol 293: H3490-3497.
12. Fujioka D, Kawabata K, Saito Y, Kobayashi T, Nakamura T, et al. (2006) Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 290: H2409-2416.
13. Unger T, (2002) The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89: 3A-9A.
14. Furuhashi M, Ura N, Higashiura K, Murakami H, Tanaka M, et al. (2003) Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 42: 76-81.
15. Ran J, Hirano T, Fukui T, Saito K, Kageyama H, et al. (2006) Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance. Metabolism 55: 478-488.
16. Li L, Wu L, Wang C, Liu L, Zhao Y, (2007) Adiponectin modulates carnitine palmitoyltransferase-1 through AMPK signaling cascade in rat cardiomyocytes. Regul Pept 139: 72-79.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, (1951) Protein measurement with the folin phenol reagent. J Biol Chem 93: 265-275.
18. Wu LP, Wang X, Li L, Zhao Y, Lu S, et al. (2008) Histone deacetylase inhibitor depsipeptide activates silenced genes through decreasing both CpG and H3K9 methylation on the promoter. Mol Cell Biol 28: 3219-3235.
19. Zhao Y, Liu J, Li L, Liu L, Wu L, (2005) Role of Ras/PKCζ/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul Pept 128: 43-50.
20. Bendall JK, Cave AC, Heymes C, Gall N, Shah AM, (2002) Pivotal role of a gp91phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105: 293-296.
21. Hong SJ, Park CG, Seo HS, Oh DJ, Ro YM, (2004) Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press 13: 236-242.
22. Pääkkö T, Ukkola O, Ikäheimo M, Kesäniemi YA, (2010) Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects. Ann Med 42: 131-137.
23. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, et al. (2007) Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13: 332-339.
24. Wade TE, Mathur A, Lu D, Swartz-Basile DA, Pitt HA, et al. (2009) Adiponectin receptor-1 expression is decreased in the pancreas of obese mice. J Surg Res 154: 78-84.
25. Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, et al. (2008) The effects of β3-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-α expressions in adipose tissues of obese diabetic KKAy mice. Eur J Pharmacol 584: 202-206.
26. Rasmussen MS, Lihn AS, Pedersen SB, Bruun JM, Rasmussen M, et al. (2006) Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity 14: 28-35.
27. Chang SP, Chen YH, Chang WC, Liu IM, Cheng JT, (2006) Increase of adiponectin receptor gene expression by physical exercise in soleus muscle of obese Zucker rats. Eur J Appl Physiol 97: 189-195.
28. Fang X, Palanivel R, Zhou X, Liu Y, Xu A, et al. (2005) Hyperglycemia- and hyperinsulinemia-induced alteration of adiponectin receptor expression and adiponectin effects in L6 myoblasts. J Mol Endocrinol 35: 465-476.
29. Guo Z, Zheng C, Qin Z, Wei P, (2010) Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats. J Pharm Pharmacol 63: 87-94.
30. Liu S, Wu HJ, Zhang ZQ, Chen Q, Liu B, et al. (2011) The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. Eur J Pharmacol 650: 384-389.
31. González CR, Caminos JE, Gallego R, Tovar S, Vázquez MJ, et al. (2010) Adiponectin receptor 2 is regulated by nutritional status, leptin and pregnancy in a tissue-specific manner. Physiol Behav 99: 91-99.
32. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U, (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276: 39721-39726.
33. Seddon M, Looi YH, Shah AM, (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93: 903-907.
34. Laskowski A, Woodman OL, Cao AH, Drummond GR, Marshall T, et al. (2006) Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes. Cardiovasc Res 72: 112-123.
35. Brandes RP, Weissmann N, Schröder K, (2010) NADPH oxidases in cardiovascular disease. Free Radic Biol Med 49: 687-706.
36. Park J, Lee J, Choi C, (2011) Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers. PLoS One 6: e23211.
37. Afanas'ev I, (2011) ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxid Med Cell Longev 2011: 293769.
38. De Giusti VC, Garciarena CD, Aiello EA, (2009) Role of reactive oxygen species (ROS) in angiotensin II-induced stimulation of the cardiac Na+/HCO3- cotransport. J Mol Cell Cardiol 47: 716-722.
39. Dikalov S, (2011) Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 51: 1289-1301.
40. Santos CX, Anilkumar N, Zhang M, Brewer AC, Shah AM, (2011) Redox signaling in cardiac myocytes. Free Radic Biol Med 50: 777-793.
41. Bedard K, Krause KH, (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313.
42. Zhang M, Perino A, Ghigo A, Hirsch E, Shah AM, (2012) NADPH oxidases in heart failure: poachers or gamekeepers? Antioxid Redox Signal [Epub ahead of print].
43. Looi YH, Grieve DJ, Siva A, Walker SJ, Anilkumar N, et al. (2008) Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 51: 319-325.
44. Sun X, He J, Mao C, Han R, Wang Z, et al. (2008) Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element. FEBS Lett 582: 3401-3407.
45. Cui XB, Wang C, Li L, Fan D, Zhou Y, et al. (2012) Insulin decreases myocardial adiponectin receptor 1 expression via PI3K/Akt and FoxO1 pathway. Cardiovasc Res 93: 69-78.
46. Touyz RM, Berry C, (2002) Recent advances in angiotensin II signaling. Braz J Med Biol Res 35: 1001-1015.
47. McWhinney CD, Dostal D, Baker K, (1998) Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes. J Mol Cell Cardiol 30: 751-761.
48. Xiao G, Mao S, Baumgarten G, Serrano J, Jordan MC, et al. (2001) Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 89: 1122-1129.
49. Zhong W, Mao S, Tobis S, Angelis E, Jordan MC, et al. (2006) Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathway. EMBO J 25: 3869-3879.
50. Ahuja P, Zhao P, Angelis E, Ruan H, Korge P, et al. (2010) Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice. J Clin Invest 120: 1494-1505.
51. Delaney J, Chiarello R, Villar D, Kandalam U, Castejon AM, et al. (2008) Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases. Neurochem Res 33: 545-550.
52. Schauwienold D, Plum C, Helbing T, Voigt P, Bobbert T, et al. (2003) ERK1/2- dependent contractile protein expression in vascular smooth muscle cells. Hypertension 41: 546-552.